High-level endoscope disinfection processes in emerging economies: Financial impact of manual process versus automated endoscope reprocessing

Journal of Hospital Infection

Volumn 86, Issue 4, 2014, Pages 250-254

  Funk, S E ^a   Reaven, N L ^a  

^a Strategic Health Resources   (United States)

Author keywords

Automatic endoscope reprocessor; Decontamination; Disinfection; Endoscopes; Infection control

Indexed keywords

ARTICLE; AUTOMATED ENDOSCOPE REPROCESSOR; CHINA; CONTROLLED STUDY; COST CONTROL; DISEASE TRANSMISSION; DISINFECTION; ENDOSCOPE; FINANCIAL MANAGEMENT; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; INSTRUMENT STERILIZATION; INTERMETHOD COMPARISON; INVESTMENT; MEDICAL DEVICE; PRACTICE GUIDELINE; PRODUCTIVITY; RUSSIAN FEDERATION; TOTAL QUALITY MANAGEMENT; AUTOMATION; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE COST; PROCEDURES; WASTE MANAGEMENT;

AUTOMATION; CHINA; DECONTAMINATION; DEVELOPING COUNTRIES; DISINFECTION; ENDOSCOPES; HEALTH CARE COSTS; HUMANS; INDIA; RUSSIA;

EID: 84897499348     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.01.007     Document Type: Article

References (26)

1. Rutala W., Weber D. Guideline for disinfection and sterilization in healthcare facilities 2008, Healthcare Infection Control Practices Advisory Committee (HICPAC), US Centers for Disease Control and Prevention, Atlanta.
2. Burdick J.S., Hambrick D. Endoscope reprocessing and repair costs. Gastrointest Endosc Clin North Am 2004, 14:717-724.
3. Martiny H., Floss H., Zühlsdorf B. The importance of cleaning for the overall results of processing endoscopes. JHosp Infect 2004, 56:S16-S22.
4. Rey J.-F., Bjorkman D., Nelson D., et al. Endoscope disinfection - a resource-sensitive approach 2011, World Gastroenterology Organization/World Endoscopy Organization Global Guidelines. World Gastroenterology Organization.
5. Hanson J.M., Plusa S.M., Bennett M.K., Browell D.A., Cunliffe W.J. Glutaraldehyde as a possible cause of diarrhoea after sigmoidoscopy. Br J Surg 1998, 85:1385-1387.
6. Ryan C., Potter G. Disinfectant colitis: rinse as well as you wash. JClin Gastroenterol 1995, 21:6-9.
7. Junicon®: final reports dated April 15-May 19, 2010, of research conducted by telephone interview. Data supplied courtesy of Advanced Sterilization Products.
8. Ofstead C.L., Wetzler H.P., Snyder A.K., Horton R. Endoscope reprocessing methods: a prospective study on the impact of human factors and automation. Gastroenterol Nurs 2010, 33:304-311. supplementary data courtesy of authors.
9. Alfa M.J., Degagne P., Olson N. Worst-case soiling levels for patient-used flexible endoscopes before and after cleaning. Am J Infect Control 1999, 27:392-401.
10. Kirkpatrick M., Smith J.R., Hoffman P., Middleton R. Bronchoscope damage and repair costs: results of a regional postal survey. Resp Care 1992, 37:1256-1259.
11. Rozman A., Duh S., Petrinec-Primozic M., Triller N. Flexible bronchoscope damage and repair costs in a bronchoscopy teaching unit. Respiration 2009, 77:325-330.
12. Mehta A., Curtis P., Scalzitti M., Meeker D. The high price of bronchoscopy: maintenance and repair of the flexible fiberoptic bronchoscope. Chest 1990, 98:448-454.
13. Chaufour X., Deva A.K., Vickery K., et al. Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. JVasc Surg 1999, 30:277-282.
14. Banerjee S., Shen B., Nelson D.B., et al. Infection control during GI endoscopy. Gastrointest Endosc 2008, 67:781-790. ASGE Standards of Practice Committee.
15. ® endoscope cleaner and reprocessor (ECR) simulated-use and clinical-use evaluation of cleaning efficacy. BMC Infect Dis 2010, 10:200.
16. Bronowicki J.P., Venard V., Monhoven N., et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. NEngl J Med 1997, 337:237-240.
17. Grenkova T., Selkova E., Aleshkin V., Melkumyan A. Ensuring infectious safety of colonoscopy. BMC Proc 2011, 5(Suppl. 6):P309.
18. Previsani N, Lavanchy D. Hepatitis B. World Health Organization; 2002. Available at: [accessed 5 February 14]. http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf?ua=1.
19. Keeffe EB. What is the prevalence rate of chronic hepatitis B in the world? Hepatitis B Foundation Expert Speakers Forum; 2004. Available at: [accessed 5.02.14]. http://www.hepb.org/expforum/speaker.aspx?speakerID=drKeefe%26language=English.
20. AVERT (AVERTing HIV and AIDS). Reports on AIDS in India, Russia, China and Brazil Available at: avert.org.
21. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
22. Al Knawy, Bandar Health care-associated transmission of hepatitis B and C viruses, an issue of clinics in liver disease (Google eBook) 25 February 2010, Elsevier Health Sciences.
23. Wiens A., Venson R., Correr C.J., Pontarolo R. Cost effectiveness of tebivudine vs lamivudine for chronic hepatitis B. Braz J Infect Dis 2011, 15:225-230.
24. Costa A., L'italien G., Nita M.E., Araujo E.S. Cost-effectiveness of entecavir vs. lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil. Braz J Infect Dis 2008, 12:368-373.
25. WHO consultation on the management of viral hepatitis in China, 2009 2009, World Health Organization, WHO, Geneva.
26. Anand A.C. Treatment of chronic hepatitis B in India: what is the cost of life?. Natl Med J India 2002, 15:317-319.